Literature DB >> 378847

Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin.

D L Peavy, R E Baughn, D M Musher, D M Musher.   

Abstract

Mice infected intravenously with Mycobacterium bovis (BCG) are 100 to 1,000 times more sensitive to the lethal effects of bacterial lipopolysaccharides (LPS). Since BCG infection results in macrophage activation and LPS may cause pathophysiological effects through interaction with this cell type, it was of interest to determine whether macrophages from BCG-infected animals were more susceptible to the toxic effects of LPS in vitro. When LPS-susceptible, C57BL/6 mice were infected with BCG, a significant reduction in the 50% lethal dose of LPS was first observed after 7 days and persisted for several weeks. Macrophages from these animals had greatly increased susceptibility to LPS in vitro, which correlated with the development of acquired cellular resistance as determined by their ability to inhibit the growth of Listeria monocytogenes. In contrast, BCG infection of C3H/HeJ mice, a strain resistant to LPS, did not alter the 50% lethal dose of LPS for these animals or increase the sensitivity of their peritoneal macrophages to LPS in vitro. These results indicate that susceptibility of BCG-infected mice to the lethal effects of LPS parallels the susceptibility of their macrophages in vitro; release of vasoactive substances from LPS-susceptible activated macrophages in vivo may be, in part, responsible for lethality.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378847      PMCID: PMC414261          DOI: 10.1128/iai.24.1.59-64.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  HYDROLASES OF MONONUCLEAR EXUDATE CELLS AND TUBERCULOSIS. I. EXUDATE CHARACTERISTICS, ESTERASES, PROTEINASES, AND LIPASE.

Authors:  A M DANNENBERG; W E BENNETT
Journal:  Arch Pathol       Date:  1963-11

2.  Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions.

Authors:  E SUTER; E M KIRSANOW
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

3.  The effect of Mycobacterium tuberculosis (BCG) infection on the resistance of mice to bacterial endotoxin and Salmonella enteritidis infection.

Authors:  J G HOWARD; G BIOZZI; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Br J Exp Pathol       Date:  1959-06

4.  Increased susceptibility of mice with brucellosis to bacterial endotoxins.

Authors:  R S ABERNATHY; G M BRADLEY; W W SPINK
Journal:  J Immunol       Date:  1958-10       Impact factor: 5.422

5.  Induction of phenotypic lymphocyte differentiation in LPS unresponsive mice by an LPS-induced serum factor and by lipid A-associated protein.

Authors:  S Koenig; M K Hoffmann; L Thomas
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

6.  Strain-dependent cytotoxic effects of endotoxin for mouse peritoneal macrophages.

Authors:  D L Peavy; R E Baughn; D M Musher
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Regulation of lipopolysaccharide-induced granulopoiesis and macrophage formation by spleen cells. I. Relationship between colony-stimulating factor release and lymphocyte activation in vitro.

Authors:  R N Apte; C F Hertogs; D H Pluznik
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

8.  Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Guérin).

Authors:  E SUTER; G E ULLMAN; R G HOFFMAN
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

9.  Effects of bacterial endotoxin on metabolism. I. Carbohydrate depletion and the protective role of cortisone.

Authors:  L J BERRY; D S SMYTHE; L G YOUNG
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

10.  LYSOSOMAL ACID HYDROLASES IN MICE INFECTED WITH BCG.

Authors:  K SAITO; E SUTER
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

View more
  15 in total

1.  The role of macrophages in LPS-induced lethality and tissue injury.

Authors:  P H Groeneveld; E Claassen; C F Kuper; N Van Rooijen
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

2.  Increased sensitivity of Corynebacterium parvum-treated mice to toxic effects of indomethacin and lipopolysaccharide.

Authors:  D A Hart
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

3.  Aspects of beneficial endotoxin-mediated effects.

Authors:  R Urbaschek; B Urbaschek
Journal:  Klin Wochenschr       Date:  1982-07-15

4.  Changes in phospholipid fatty acid composition and triacylglycerol content in mouse tissues after infection with bacille Calmette-Guérin.

Authors:  S K Jackson; J M Stark; S Taylor; J L Harwood
Journal:  Br J Exp Pathol       Date:  1989-08

Review 5.  Alteration of non-specific resistance to infection with Listeria monocytogenes.

Authors:  C H Wirsing von König; B Heymer; H Finger; P Emmerling; H Hof
Journal:  Infection       Date:  1988       Impact factor: 3.553

6.  Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection.

Authors:  R W Stokes; F M Collins
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Evidence for lipid peroxidation in endotoxin-poisoned mice.

Authors:  D L Peavy; E J Fairchild
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Production of lymphocyte activating factor in vivo.

Authors:  P R Wood; L Andrus; I A Clark
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

9.  Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.

Authors:  M Ogata; S Yoshida; M Kamochi; A Shigematsu; Y Mizuguchi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Effect of route of Mycobacterium bovis BCG administration on induction of suppression of sporozoite immunity in rodent malaria.

Authors:  L L Smrkovski
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.